DENVER - s4story -- Slumber, maker of Deep Zzzs and Pure Sleep™, today announced three additions to its sleep portfolio: Magnesium Glycinate, a more potent Extra Strength Deep Zzzs, and a new clinically-backed Deep Zzzs formula, all shaped directly by more than 1,200 customer surveys.

"Our customers told us exactly what they needed," said Tony Schwartz, Head of Consumer Insights at Slumber. "They were already stacking our gummies with other manufacturers' products, so we built what they were reaching for and improved what they already loved."

Customers said magnesium glycinate was, by far, the supplement they most often paired with their gummies to fall asleep faster and stay asleep longer. Slumber's new Magnesium Glycinate delivers 350mg of magnesium glycinate plus a 50mg sucrosomial layer for better absorption, void of any aftertaste or stomach discomfort common to other magnesium products. Paired with a gummy, it forms Slumber's most efficacious sleep stack to-date.

More on S For Story

• AI Visibility Labs LLC - Dallas Texas - July 16 2026
• NextBoat's AI-Powered Marine Marketplace Gains Momentum as Record Growth Signals an Inflection Point for Investors (N Y S E American: NXB)
• Author Terry Crain of the faBgear Company to Release New Book on Beatles Novelty Songs
• Earth First! Thoughtstorms, Parables, and Poems by J.T. Hollin Jr. Now Available for Pre-Order
• Stepping Off the Grid: Savista Retreat Announces New Experiential Packages in Jaipur for Travellers

Consumer-facing research drove an upgrade to Slumber's flagship formula. In a 500-person study, the original Deep Zzzs improved sleep by 72 minutes a night, and nine in ten participants called it the best sleep aid they'd ever tried, prescription included. Customers asked for more, so Slumber formulated Extra Strength Deep Zzzs, raising every ingredient concentration to further cut nighttime awakenings and extend total sleep.

For customers who want Slumber's efficacy backed by clinical studies, the brand also launched Deep Zzzs, combining 25mg CBN and 250mg of the clinically studied ingredient Maizinol® with TerpaCalm™, Slumber's proprietary calming terpene blend engineered around pathways linked to sleep and relaxation. The formula is clinically studied using the Pittsburgh Sleep Quality Index (PSQI).

"This new offering gives us the same formulation rigor for a broader audience, backed by the clinically studied Maizinol®. We continue to prioritize outcomes on behalf of the people who aren't getting enough sleep," said Alec Tremaine, Chief Revenue Officer.

All three products are available now at slumbercbn.com and through Slumber's retail partners.